Results 111 to 120 of about 760,866 (212)

Premature ovulation; is any risk small enough to take when avoidable? [PDF]

Reproductive BioMedicine Online, 2021
Engin, Turkgeldi, Baris, Ata
openaire   +2 more sources

The persistently patent arterial duct in the premature infant [PDF]

, 2001
The presence of a persistently patent arterial duct is common in premature neonates and may be associated with high morbidity. Early accurate diagnosis, assessment of the significance of the left to right shunt and prompt treatment are required to ...
Gardiner, Helena Maria, Azzopardi, D.V., Karatza, Ageliki A.   +2 more
core  

X chromosome genes and premature ovarian failure.

, 2000
Premature ovarian failure (POF) is a disorder characterized by lack of ovulation and elevated levels of serum gonadotropins before the age of 40. The etiology of POF is not known but different environmental and genetic factors are involved, suggesting ...
Toniolo D, Bione S
core   +1 more source

STUDY OF PRIMORDIAL FOLLICLE, CORPORA LUTEA AND Fmr1 mRNA LEVELS FROM OVARIUM OF Fmr1 GENE PREMUTATION MICE [PDF]

, 2010
Background : The FMR1 gene involves in fragile X-associated disorders (FAD), including the fragile X mental retardation syndrome, primary ovarian insufficiency (POI) and Fragile X associated tremor/ataxia syndrome.
Santoso, Santoso
core   +1 more source

Ovulatory signals alter granulosa cell behavior through YAP1 signaling

Reproductive Biology and Endocrinology, 2019
Background The Hippo pathway plays critical roles in regulating cell proliferation, differentiation and survival among species. Hippo pathway proteins are expressed in the ovary and are involved in ovarian function.
Tianyanxin Sun, Francisco J. Diaz
doaj   +1 more source

Clinical parameters that predict a premature LH rise in patients undergoing ovarian stimulation for IVF

Gynecological Endocrinology
Background: Normal reproductive function requires adequate regulation of follicle stimulating hormone (FSH) and luteinizing hormone (LH) secretion. During ovarian stimulation for in-vitro fertilization (IVF), some patients will demonstrate an early rise ...
Maya Nasatzky, Yonathan Belicha, Ofer Fainaru   +2 more
doaj   +1 more source

Response to: Premature ovulation; is any risk small enough to take when avoidable? [PDF]

Reproductive BioMedicine Online, 2021
Ioannis E, Messinis, Christina I, Messini, George, Anifandis, Alexandros, Daponte   +3 more
openaire   +2 more sources

Role of IL-6 in Physiology and Pathology of the Ovary

Clinical and Experimental Obstetrics & Gynecology
Objective: We aimed to explore the roles of interleukin (IL)-6 in ovarian physiology and pathology. Mechanism: IL-6 is a common and important cytokine in numerous ...
Bingyao Tan, Jing Wang
doaj   +1 more source

Resolved Neutropenia, Thrombocytopenia, and Premature Ovarian Insufficiency in a G6PC3-Deficient Patient Treated With an SGLT2-Inhibitor

Annals of Internal Medicine: Clinical Cases
Glucose-6-phosphatase catalytic subunit 3 (G6PC3) deficiency is an ultrarare metabolic disorder characterized by congenital neutropenia and multisystem abnormalities and accumulation of 1,5-anhydroglucitol.
Birgit I. Veldman, Johan Gerrits, Angelique J. Goverde, Nanda M. Verhoeven-Duif, Judith J.M. Jans, Roger E.G. Schutgens   +5 more
doaj   +1 more source

Prevalence of an endogenous LH rise following final GnRH antagonist dose in the IVF antagonist protocol

European Journal of Obstetrics & Gynecology and Reproductive Biology: X
Background: The GnRH antagonist protocol is widely used in IVF/ICSI treatments. It involves daily injections of a GnRH antagonist starting on stimulation day 5 or later to prevent premature ovulation by suppressing the endogenous gonadotropin surge ...
K. Løssl, N. Friis Wang, J.W. Bogstad, T.V. Dam, N. Bülow, J.A. Bøtkjær, M.R. Petersen, L.B. Dessing, B. Oxlund-Mariegaard, M.M. Celicanin, A. Pinborg, L.S. Mamsen, L.C. Poulsen, C. Yding Andersen   +13 more
doaj   +1 more source